CARRA Registry for Pediatric Rheumatic Diseases

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Recruiting Observational Study
Rheumatic Joint Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 21
Sex
Any
Study type
Observational
Participants needed
20,000 (estimated)
Sponsor
Duke University · Other
Who this trial is looking for

This trial is looking for children and teenagers with rheumatic joint diseases. If you join, you will help researchers gather important information about treatments used for these conditions.

Are You a Good Fit for This Trial?

You may be able to join if

  • I started having rheumatic disease before age 16 for JIA
  • I started having rheumatic disease before age 19 for other conditions
  • I can provide written consent or my parent can if needed
  • I am willing to be contacted by study staff in the future

You may not be able to join if

  • I am older than 21 years of age at the time of enrollment

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A). 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study pro…
Contacts

Mara L Becker, MD, MSCE

(919) 419-5032

mara.becker@duke.edu

CONTACT

Mary Beth Son, MD

(617) 919-6083

marybeth.son@childrens.harvard.edu

CONTACT